We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
908 Devices To Exhibit at ASMS and Present Key Developments in Accelerating Proteomics Workflows
Product News

908 Devices To Exhibit at ASMS and Present Key Developments in Accelerating Proteomics Workflows

908 Devices To Exhibit at ASMS and Present Key Developments in Accelerating Proteomics Workflows
Product News

908 Devices To Exhibit at ASMS and Present Key Developments in Accelerating Proteomics Workflows


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "908 Devices To Exhibit at ASMS and Present Key Developments in Accelerating Proteomics Workflows "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

At the American Society of Mass Spectrometry (ASMS) conference October 31 to November 4 in Philadelphia, 908 Devices Inc. (Nasdaq: MASS) presented several talks and posters on the use of high-pressure mass spectrometry and microfluidics separation technologies to accelerate drug discovery workflows, including in metabolomics and proteomics applications. The company, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, is also launching a new ZipChip assay kit that enables fast and accurate identification and quantitation of oligonucleotides. 

A Revolution in Chemical and Biochemical Analysis
 

Proteomics and metabolomics continue to increase in importance in the development of new therapeutics. “Widely available genetic sequencing tools unlocked genomic knowledge and discovery, and it is widely acknowledged that the proteomics and metabolomics revolutions are next,” said Dr. Christopher D. Brown, CTO and co-founder, 908 Devices. “Research in these areas have already dramatically expanded the visibility we have into both the state and trajectory of extremely complex biological systems.”
 

Bolstered by the remarkable success of rapid COVID-19 vaccine development, scientists are looking for more tools to accelerate discovery and development workflows. At ASMS, Drs. Scott Mellors and Will Thompson, research scientists at 908 Devices, will present recent microfluidic prototype chip developments and associated analysis algorithm approaches for the company’s ZipChip ecosystem in the proteomics and metabolomics application spaces. Jarrod Marto and He Zhu, leading researchers at Dana-Farber Cancer Institute in Boston, are utilizing the prototypes to perform proteomics assays of deubiquitinating enzymes. At ASMS, they will present their ‘warp-speed profiling’ in comparison to a traditional liquid chromatography-based workflow.
 

ZipChip integrates with Thermo Fisher, Sciex, and Bruker mass spectrometers and leverages microfluidic-based Capillary Electrophoresis (CE) and electrospray ionization technology to minimize sample prep burden, perform high-resolution separations and directly introduce samples into a mass spec.
 

Other presentations at ASMS include a talk and poster on the new ZipChip Oligos assay kit, which provides a fast and simple means to obtain high-resolution separation and mass spec data from a wide range of oligonucleotides. Two posters will also be presented on quantitation of metabolites in cell culture media using Rebel, a desktop CE-MS analyzer, which enables biopharma researchers to accelerate process development cycles and maximize their bioreactor utilization.
 

Advertisement